Standard Withdrawn, No replacement   Last Updated: Aug 17, 2022 Track Document
ASTM D4774-11(2017)

Standard Specification for User Applied Drug Labels in Anesthesiology (Withdrawn 2022)

Standard Specification for User Applied Drug Labels in Anesthesiology (Withdrawn 2022) D4774-11R17 ASTM|D4774-11R17|en-US Standard Specification for User Applied Drug Labels in Anesthesiology (Withdrawn 2022) Standard new BOS Vol. 15.10 Committee F02
$ 0.00 Out of stock

Significance and Use

5.1 The objective of this specification is to facilitate identification of drugs in syringes filled by the user. The use of colors is intended only as an aid in identification of drug groups and does not absolve the user from the duty to read the label to correctly identify the drug prior to use.

5.2 The user may alternatively use black and white labels rather than these colored labels.

Abstract

This specification covers the size, color and pattern, and type used on labels applied to unlabeled syringes filled by the users or their agents to identify the drug content. This specification is not intended to cover labels applied by the drug manufacturer. The size and background color requirements of drug labels are presented in details. The type and color requirements of printing for drug labels are presented in details.

Scope

1.1 This specification covers the size, color, pattern, and type used on labels applied to unlabeled syringes filled by the users or their agents to identify the drug content. This specification is not intended to cover labels applied by the drug manufacturer.

FIG. 1 Standard Background Colors for User Applied Syringe Drug Labels

Standard Background Colors for User Applied Syringe Drug LabelsStandard Background Colors for User Applied Syringe Drug Labels

FIG. 2 Label for an Antagonist Drug

 Label for an Antagonist Drug Label for an Antagonist Drug

FIG. 3 Reversed Plate Printing Used to Identify "SUCCINYLcholine," "EPINEPHrine," and Beta Blockers, "ESMOlol," "LABATolol," and "METOprolol"

 Reversed Plate Printing Used to Identify "SUCCINYLcholine," "EPINEPHrine," and Beta Blockers, "ESMOlol," "LABATolol," and "METOprolol" Reversed Plate Printing Used to Identify "SUCCINYLcholine," "EPINEPHrine," and Beta Blockers, "ESMOlol," "LABATolol," and "METOprolol"

FIG. 4 Optional Printing

Optional PrintingOptional Printing

Note—Bold upper-case type is shown for first or first and second syllables of the drug name.

FIG. 5 Drug Name and Dosage

 Drug Name and Dosage Drug Name and Dosage

FIG. 6 Alternative Label Showing Concentration in Percent and mg/mL

 Alternative Label Showing Concentration in Percent and mg/mL Alternative Label Showing Concentration in Percent and mg/mL

1.2 The values stated in SI units are to be regarded as the recommended values. The use of inch-pound system values, not being exact equivalents, may result in nonconformance with the standard.

1.3 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety, health, and environmental practices and determine the applicability of regulatory limitations prior to use.

1.4 This international standard was developed in accordance with internationally recognized principles on standardization established in the Decision on Principles for the Development of International Standards, Guides and Recommendations issued by the World Trade Organization Technical Barriers to Trade (TBT) Committee.

Language unavailable
Format unavailable
Related
Reprints and Permissions
Reprints and copyright permissions can be requested through the
Copyright Clearance Center